glp 1 based therapies GLP-1-based therapies, including GLP-1, GLP-1R agonists and DPP-4 Nutritional and lifestyle supportive care

Counsel patients regarding the potential risk for MTC with the use of liraglutide injection and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness)

Those paying out-of-pocket reported an average monthly cost of $196

GLP1-RAs is clinically used to treat T2DM and promote weight loss in obese individuals

GLP-1 Receptor Agonists are expected to dominate the market growth in the forecast period because GLP1RAs are endorsed by international guidelines for the management of type 2 diabetes when treatment escalation is necessary after metformin and lifestyle interventions have been implemented

GLP-1 medications appear to provide kidney protection beyond what glucose control alone achieves

When food enters the digestive system, specialised cells in the gut release GLP-1, which stimulates insulin secretion, slows gastric emptying, and promotes feelings of satiety